MedTrace Logo

Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

NCT04993378 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-08-06

No results posted yet for this study

Summary

To vertify the function of EV-score on predicting \& monitoring immunotherapeutic outcomes of GC

Conditions

  • Advanced Gastric Adenocarcinoma
  • Immunotherapy

Interventions

DEVICE

EV-array

Collect peripheral blood sample of 40 gastric cancer patients pre-treatment. Blood samples will be transferred to central lab to detect EV-score by EV-array. Tumor response evaluation will be performed after two cycles of chemotherapy by CT/MRI based on RECIST. Clinical data, including tumor stage, metastastic organ, regimen, objective response, progression free survival, overall survival, etc, will be collected according to study protocol.

Sponsors & Collaborators

  • Shen Lin

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-04-30
Completion
2021-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04993378 on ClinicalTrials.gov